Bio Essence Corp (BIOE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 600K 1.2M 1.8M Q3 '24: 134.7K Q4 '24: 147.6K Q1 '25: 22.2K Q2 '25: 259.1K Q3 '25: 136.8K Q4 '25: 1.5M Q1 '26: 500.5K Q2 '26: 794.7K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 400K 800K 1.2M Q3 '24: 81K Q4 '24: 106.9K Q1 '25: 20.6K Q2 '25: 168.6K Q3 '25: 95.8K Q4 '25: 1.1M Q1 '26: 319.4K Q2 '26: 470.3K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-400K 0 400K 800K 1.2M Q3 '24: -146.4K Q4 '24: 3.9K Q1 '25: -205.1K Q2 '25: 61.2K Q3 '25: 14.3K Q4 '25: 1M Q1 '26: 215.8K Q2 '26: 279.3K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q3 '24: -1.2M Q4 '24: -27.6K Q1 '25: -205.8K Q2 '25: 59.9K Q3 '25: 13K Q4 '25: 1M Q1 '26: 205.4K Q2 '26: 270.1K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 150K 300K 450K Q3 '24: 53.7K Q4 '24: 40.7K Q1 '25: 1.6K Q2 '25: 90.5K Q3 '25: 41K Q4 '25: 336K Q1 '26: 181.2K Q2 '26: 324.4K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-500K 0 500K 1M 1.5M Q3 '24: 357.1K Q4 '24: 423.1K Q1 '25: -26.1K Q2 '25: 167.8K Q3 '25: 187K Q4 '25: 1.2M Q1 '26: -412K Q2 '26: 59.6K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-900K -600K -300K 0 300K 600K 900K Q4 '20: -242.5K Q1 '21: -168.2K Q2 '21: -830.9K Q3 '21: -182.1K Q4 '21: -232.4K Q3 '22: -182.3K Q4 '22: -134.8K Q4 '23: -204.1K Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '21 Q3 '22 Q4 '22 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 38M Q2 '24: 38M Q3 '24: 38M Q1 '25: 38M Q2 '25: 38M Q3 '25: 38M Q1 '26: 45M Q2 '26: 50.9M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.06 -0.04 -0.02 0.00 0.02 0.04 0.06 Q3 '23: -0.03 Q4 '23: -0.04 Q1 '24: -0.03 Q2 '24: -0.03 Q3 '24: -0.05 Q4 '24: -0.04 Q1 '25: -0.05 Q2 '25: -0.04 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.